Abstract:
The present invention relates to a novel colchicine derivative or a pharmaceutically acceptable salt thereof and to a composition for preventing or treating cancer comprising the same as an active ingredient. The novel colchicine derivative of the present invention significantly reduces the expression of polo-like kinase (Plk-1) and stimulates the apoptosis of cancer cells while markedly suppressing the growth of the cancer cells by activating p21 and p53, thereby being capable of being usefully applied to an effective treatment composition on various cancers.
Abstract:
본 발명은 신규한 티에노피리미딘 유도체 및 이를 유효성분으로 포함하는 당뇨병 및 다양한 당뇨 관련 질환의 예방 또는 치료용 약제학적 조성물에 관한 것이다. 본 발명의 티에노피리미딘 유도체는 당-의존적 인슐린 분비를 증가시키고 섭식과 체중 증가의 억제효과가 있는 GPR119(G protein-coupled receptor 119)의 활성을 효율적으로 항진시킴으로써 당 및 지질 대사를 개선시켜, 당뇨 뿐 아니라, 비만, 고지혈증, 당뇨병성 혈관질환 등 다양한 당뇨병성 합병증에 대한 효율적인 예방 및 치료용 조성물로 유용하게 이용될 수 있다.
Abstract:
본 발명은 콕시디움 억제 활성을 갖는 1-[4-(4-니트로-펜옥시)-페닐]-프로판-1-온(1434NJ0221)을 유효성분으로 함유하는 조성물에 관한 것으로, 상세하게는 본 발명의 1-[4-(4-니트로-펜옥시)-페닐]-프로판-1-온(1434NJ0221)은 콕시디움, 즉 톡소포자충의 증식에 뛰어난 억제 효과를 나타내므로 톡소포자충 및 콕시디움에 기인한 질환의 예방 및 치료에 유용하게 이용될 수 있다.
Abstract:
PURPOSE: A 1-[2-(4-nitro-phenyl)-benzooxazole-5-yl]-propane-1-one compound(1124JH0013) is provided to ensure excellent anti-coccidium effect. CONSTITUTION: A 1-[2-(4-nitro-phenyl)-benzooxazole-5-yl]-propane-1-one compound having anti-coccidium effect or pharmaceutically acceptable salt thereof is denoted by structural formula A. A veterinary composition for preventing or treating diseases caused by coccidium contains the compound of formula A or the salt as an active ingredient. A pharmaceutical composition for preventing and treating diseases caused by coccidium contains the compound as an active ingredient. An animal feed additive contains the compound of formula A as an active ingredient.
Abstract:
본 발명은 이미다조 페닐테트라졸 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 골다공증, 비만, 당뇨 또는 고지혈증의 예방 또는 치료용 약학적 조성물에 관한 것으로서, 상기 유도체는 TAZ 단백질을 조절하므로, 골다공증, 비만, 당뇨 또는 고지혈증의 예방 또는 치료에 유용하게 사용될 수 있다. 이미다조 페닐테트라졸 유도체, TAZ, 골다공증, 비만, 당뇨, 고지혈증
Abstract:
PURPOSE: A fluorophenyl oxazole derivative with antifungal activity is provided to selectively suppress protein synthesis of pathogenic fungus and to use as various antifungal agents. CONSTITUTION: A fluorophenyl oxazole derivative is denoted by chemical formula 1. A method for preparing fluorophenyl oxazole derivative or pharmaceutically acceptable salt thereof comprises: a step of performing nitration of a compound of chemical formula 6 to obtain a compound of chemical formula 7; a step of reducing the nitro compound of chemical formula 7 to obtain hydroxyl amine compound of chemical formula 8; a step of performing acylation of the hydroxy amine compound of chemical formula 8 with a compound of chemical formula 9 to obtain an amide compound of chemical formula 10; and a step of cyclizing the amide compound of chemical formula 10 to obtain the compound of chemical formula 1.
Abstract:
PURPOSE: A 2-sulfanyl-benzimidazole-4-carboximidazole derivative is provided to repair damaged DNA and suppress poly(ADP-ribose)polymerase-1(PARP-1) which is an enzyme causing cell damage and apoptosis. CONSTITUTION: A 2-sulfanyl-benzimidazole-4-carboximidazole derivative is denoted by chemical formula 1. A 2-sulfanyl-benzimidazole-4-carboximidazole derivative is prepared by performing alkylation of a compound of chemical formula 2 and a compound of chemical formula 3. A basic catalyst is used in the preparation. The basic catalyst is carbonate including sodium carbonate, potassium carbonate, or cesium carbonate; hydroxide including potassium hydroxide or sodium hydroxide; hydride including sodium hydride; alkoxide including sodium methoxide and sodium t-butoxide; triethylamine; or pyridine. A pharmaceutical composition for preventing or treating diseases caused by over-activation contains the 2-sulfanyl-benzimidazole-4-carboximidazole derivative or its pharmaceutically acceptable salt as an active ingredient.